SUMO3 Protein, Human, Recombinant (HEK293, His)

Name: SUMO3 Protein, Human, Recombinant (HEK293, His)
Brand: TargetMol
SKU: TMPJ-01022
Rating: 4.5 (1 reviews)

(Synonyms: Ubiquitin-like protein SMT3A, SUMO-3, SUMO-2, Smt3A, SMT3 homolog 1, Small ubiquitin-related modifier 3) Copy Product Info

Synonyms: Ubiquitin-like protein SMT3A, SUMO-3, SUMO-2, Smt3A, SMT3 homolog 1, Small ubiquitin-related modifier 3

Catalog No. TMPJ-01022 Copy Product Info

Small ubiquitin-like modifier (SUMO), also known as SUMO homologue and SMT3, is a member of the superfamily of ubiquitin-like polypeptides that become covalently attached to various intracellular target proteins as a way to alter their function, location, and/or half-life. Small ubiquitin-like modifiers include SUMO1, SUMO2, SUMO3, and SUMO4. Except for SUMO4, all other SUMOs are ubiquitously expressed, including in the brain. In human, SUMO2 and SUMO3 are two highly homologous proteins, collectively called SUMO2/3. Several studies suggest that SUMO3 are associated with pathogenesis in several neurological diseases, including Alzheimer's disease, Parkinson's disease, and cerebral ischemia/stroke.

SUMO3 Protein, Human, Recombinant (HEK293, His)

Pack Size	Price	USA Stock	Global Stock
10 µg	$72	35 days	35 days
20 µg	$107	35 days	35 days
50 µg	$183	35 days	35 days
100 µg	$335	35 days	35 days
200 µg	$615	35 days	35 days
500 µg	$1,390	35 days	35 days
1 mg	$1,980	35 days	35 days

For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)

Add to Cart

Add to Quotation

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Batch Information

Select Batch

Purity:>99.99%

Appearance:Lyophilized powder

Color:White

Resource Download

COA User Guide of Recombinant Proteins

Product Introduction

Bioactivity

Bioactivity	Activity has not been tested. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Description	Small ubiquitin-like modifier (SUMO), also known as SUMO homologue and SMT3, is a member of the superfamily of ubiquitin-like polypeptides that become covalently attached to various intracellular target proteins as a way to alter their function, location, and/or half-life. Small ubiquitin-like modifiers include SUMO1, SUMO2, SUMO3, and SUMO4. Except for SUMO4, all other SUMOs are ubiquitously expressed, including in the brain. In human, SUMO2 and SUMO3 are two highly homologous proteins, collectively called SUMO2/3. Several studies suggest that SUMO3 are associated with pathogenesis in several neurological diseases, including Alzheimer's disease, Parkinson's disease, and cerebral ischemia/stroke.
Species	Human
Expression System	HEK293 Cells
Tag	C-6xHis
Accession Number	P55854
Amino Acid	Ser2-Gly92
Construction	Ser2-Gly92
Protein Purity	Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Endotoxin	< 0.1 ng/µg (1 EU/µg) as determined by LAL test.
Formulation	20mM Citrate, 10% Trehalose，5% Mannitol，50mM NaCl, 0.05% Tween80，pH 3.5
Reconstitution	Reconstitute the lyophilized protein in distilled water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing.
Synonyms	Ubiquitin-like protein SMT3A, SUMO-3, SUMO-2, Smt3A, SMT3 homolog 1, Small ubiquitin-related modifier 3
Research Background	Small ubiquitin-like modifier (SUMO), also known as SUMO homologue and SMT3, is a member of the superfamily of ubiquitin-like polypeptides that become covalently attached to various intracellular target proteins as a way to alter their function, location, and/or half-life. Small ubiquitin-like modifiers include SUMO1, SUMO2, SUMO3, and SUMO4. Except for SUMO4, all other SUMOs are ubiquitously expressed, including in the brain. In human, SUMO2 and SUMO3 are two highly homologous proteins, collectively called SUMO2/3. Several studies suggest that SUMO3 are associated with pathogenesis in several neurological diseases, including Alzheimer's disease, Parkinson's disease, and cerebral ischemia/stroke.

Chemical Properties

Molecular Weight

18-28 kDa (reducing condition)

Storage & Solubility Information

Shipping	In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice.
Storage	Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.